Loading organizations...
Based in New York City, Brellium operates an artificial intelligence-powered clinical compliance platform that automatically audits one hundred percent of patient charts against payer, regulatory, and clinical quality standards. The software-as-a-service solution identifies documentation errors in real-time, delivers corrective instructions to healthcare providers, and offers a reimbursement guarantee if a payer initiates clawbacks on approved charts. Primarily serving behavioral health clinics and medical documentation teams, the company operates a subscription business model generating under $5 million in annual revenue. Operating at scale, Brellium has audited millions of patient records and currently supports a user base of more than 250,000 healthcare providers. The enterprise maintains a workforce of 70 employees and recently secured $16.7 million in venture funding during May 2025 to support its continued expansion. The healthcare compliance organization was officially established in 2021.
Brellium has raised $28.0M across 2 funding rounds.
Brellium has raised $28.0M in total across 2 funding rounds.
Brellium has raised $28.0M across 2 funding rounds. Most recently, it raised $17.0M Series A in March 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 1, 2025 | $17M Series A | Hayley Barna | DCM | Announced |
| Nov 1, 2024 | $11M Series A | — | American Express Ventures, Moderne Ventures, Rising Tide Partners, Touchdown Ventures, Western Technology Investment, Wolfpack Ventures | Announced |
Brellium is an AI-powered clinical compliance platform that automates chart reviews for healthcare providers, ensuring adherence to payer requirements and clinical quality standards.[1][2][3] It serves clinics and organizations in specialties like behavioral health, ABA (applied behavior analysis), home health, hospice, weight loss, chronic care management, and primary care, solving the problem of labor-intensive manual audits that lead to errors, compliance risks, and reimbursement losses.[1][2][4] Customers including Grow Therapy, Rula, Headspace, Hopebridge, Lightfully Behavioral Health, and Talkiatry use it to audit millions of patient visits across all 50 U.S. states, supporting 250,000 providers; results include 87% reduction in auditing time for Lightfully and over 80% QA cost cuts for DoubleCare ABA.[1][2]
The platform proactively scans every patient visit in real-time, flagging issues like copy-pasted notes, contraindicated medications, billing discrepancies, and patient condition declines, then provides instant fix instructions—backing its accuracy with a guarantee to cover any payer clawbacks on approved charts.[1][2][3]
Brellium emerged from co-founder Zach Rosen's personal experience with a medical misdiagnosis, which highlighted how documentation gaps undermine care quality and burden providers.[1][2] Rosen partnered with three co-founders to build an AI solution automating chart reviews for clinical quality, payer compliance, and billing.[1] The company, headquartered in New York City with under 25 employees and revenue below $5 million, recently raised $16.7 million in Series A funding led by First Round Capital and Left Lane Capital, with participation from Menlo Ventures, Digital Health Venture Partners, and angels like Headway's CEO.[1][3] This capital supports team expansion, product development, and adoption in areas like mental health, weight loss, autism, and hospice.[1]
Brellium rides the wave of AI-driven healthcare automation, addressing surging patient volumes, complex payer rules, and quality demands amid staffing shortages.[1][2] Its timing aligns with post-pandemic growth in virtual and specialty care (e.g., mental health, ABA), where manual compliance fails to scale.[1] Favorable market forces include rising AI adoption in health tech—evidenced by its funding from top VCs—and regulatory pressures for accurate billing, which its platform mitigates to protect revenue.[1][3] By enabling providers like Rula and Headspace to handle millions of visits compliantly, Brellium influences the ecosystem, elevating care standards, cutting costs, and paving the way for data-driven improvements in U.S. healthcare.[2][5]
Brellium is poised to expand beyond current specialties into broader healthcare verticals, leveraging its $16.7M funding for team growth and product enhancements amid AI health tech's rapid evolution.[1] Trends like payer scrutiny, value-based care, and AI scalability will propel it, potentially capturing more of the $5M+ compliance market as providers prioritize efficiency. Its influence could grow by setting new benchmarks for guaranteed, proactive quality assurance, ultimately helping redefine U.S. care standards from reactive fixes to preventive excellence—echoing its founding mission to fix systemic documentation failures.[2][5]
Brellium has raised $28.0M in total across 2 funding rounds.
Brellium's investors include Hayley Barna, DCM, American Express Ventures, Moderne Ventures, Rising Tide Partners, Touchdown Ventures, Western Technology Investment, Wolfpack Ventures.
